Three pharmaceutical companies headquartered in Osaka have jointly started shipping pharmaceuticals in Japan this month.
Amid concerns about a shortage of drivers, we would like to improve the efficiency of logistics.
According to the announcement, three companies, Ono Pharmaceutical Co., Ltd., Shionogi Pharmaceutical Co., Ltd., which are all headquartered in Osaka, and Mitsubishi Tanabe Pharma Corporation, have started efforts to jointly transport pharmaceuticals in Japan this month.
Specifically, by utilizing the nationwide distribution facilities of a subsidiary of Suzuken, a major pharmaceutical wholesaler, the products produced at each company's factory are once transported to the facility, and then transported from this facility to the wholesale company. , we are trying to improve efficiency by mixing the products of each company.
Through this initiative, we expect to be able to reduce the number of trucks in operation to about one-third of what it used to be, and we are considering expanding joint transportation initiatives in the future if there are companies that wish to participate.
Amid demands for responses to the "2024 problem," in which regulations on overtime work by truck drivers will be tightened, companies want to improve the efficiency of logistics and reduce carbon dioxide emissions.
Joint transport initiatives have already begun with beer and food manufacturers, and attention is being paid to whether they will spread to the pharmaceutical industry as well.